GENMAB A/S -SP ADR (GMAB) Top Institutional Shareholders

GENMAB A/S -SP ADR (GMAB) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026. The institutional investors covered on this page collectively reported approximately $2.22B in GMAB holdings during the latest filing period.

Orbis Allan Gray Ltd is currently the largest disclosed institutional shareholder of GMAB tracked by InsiderSet, reporting ownership valued at approximately $346.79M in its March 31, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $374.84M, representing an estimated gain of +8.09% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 70% of the total disclosed GMAB value among the investors covered in this analysis. Major shareholders include Orbis Allan Gray Ltd, Alliancebernstein L.P., Paradigm Biocapital Advisors Lp, and several other long-term asset managers with concentrated positions in GENMAB A/S -SP ADR (GMAB).

This page ranks the largest institutional GMAB shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

268

Total Reported Value

$2.22B

Largest Holder

Orbis Allan Gray Ltd

Largest Position

$346.79M

Insider Transactions (90d)

0

Latest Filing Quarter

Q2 2026

New Institutional Positions

97

Funds Exiting Positions

0

Page 1 of 6
NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Orbis Allan Gray Ltd1.46%12,925,578$346,793,258$374,841,762+$28,048,504+8.09%
Alliancebernstein L.P.0.10%9,557,149$294,360,189$277,157,321-$17,202,868-5.84%
Paradigm Biocapital Advisors Lp4.37%7,967,836$213,777,040$231,067,244+$17,290,204+8.09%
Arrowstreet Capital, Limited Partnership0.07%4,975,324$133,487,943$144,284,396+$10,796,453+8.09%
Blackrock, Inc.0.00%4,536,565$121,716,030$131,560,385+$9,844,355+8.09%
Renaissance Technologies LLCJim Simons0.19%4,414,550$118,442,377$128,021,950+$9,579,573+8.09%
Deep Track Capital, Lp2.03%3,663,250$98,284,998$106,234,250+$7,949,252+8.09%
Harding Loevner Lp0.89%3,231,601$86,704,217$93,716,429+$7,012,212+8.09%
Deerfield Management Company, L.P.0.78%2,462,000$66,055,460$71,398,000+$5,342,540+8.09%
First Trust Advisors Lp0.05%2,461,342$66,037,805$71,378,918+$5,341,113+8.09%
Two Sigma Investments, Lp0.05%2,339,432$62,766,961$67,843,528+$5,076,567+8.09%
Morgan Stanley0.00%2,184,701$58,615,594$63,356,329+$4,740,735+8.09%
Federated Hermes, Inc.0.05%1,251,590$33,580,160$36,296,110+$2,715,950+8.09%
Franklin Resources Inc0.01%1,193,145$32,012,080$34,601,205+$2,589,125+8.09%
Pictet Asset Management Holding Sa0.03%1,077,471$28,908,547$31,246,659+$2,338,112+8.09%
Fmr Llc0.00%1,011,726$27,144,600$29,340,054+$2,195,454+8.09%
Northern Trust Corp0.00%950,534$25,502,826$27,565,486+$2,062,660+8.09%
Goldman Sachs Group Inc0.00%931,259$24,985,679$27,006,511+$2,020,832+8.09%
Envestnet Asset Management Inc0.01%862,301$23,135,532$25,006,729+$1,871,197+8.09%
Russell Investments Group, Ltd.0.02%797,068$21,385,352$23,114,972+$1,729,620+8.09%
Millennium Management Llc0.02%792,293$21,257,221$22,976,497+$1,719,276+8.09%
Perpetual Ltd0.31%758,503$20,350,635$21,996,587+$1,645,952+8.09%
Sofinnova Investments, Inc.1.01%752,261$20,183,163$21,815,569+$1,632,406+8.09%
Qube Research & Technologies Ltd0.03%677,346$18,173,193$19,643,034+$1,469,841+8.09%
Alyeska Investment Group, L.P.0.05%645,481$17,318,255$18,718,949+$1,400,694+8.09%
American Century Companies Inc0.01%538,944$14,459,868$15,629,376+$1,169,508+8.09%
Cibc World Market Inc.0.02%488,266$13,100,177$14,159,714+$1,059,537+8.09%
Oppenheimer Asset Management Inc.0.14%457,508$12,274,939$13,267,732+$992,793+8.09%
Wells Fargo & Company/Mn0.00%319,592$8,574,653$9,268,168+$693,515+8.09%
Hudson Bay Capital Management Lp0.05%310,000$8,317,300$8,990,000+$672,700+8.09%
Ubs Group Ag0.00%298,132$7,998,882$8,645,828+$646,946+8.09%
Quantinno Capital Management Lp0.01%282,498$7,579,431$8,192,442+$613,011+8.09%
Eagle Global Advisors Llc0.24%244,565$6,561,679$7,092,385+$530,706+8.09%
Bank Of America Corp0.00%241,520$6,479,970$7,004,080+$524,110+8.09%
Bnp Paribas Financial Markets0.00%227,587$6,106,159$6,600,023+$493,864+8.09%
Assetmark, Inc0.01%224,144$6,013,784$6,500,176+$486,392+8.09%
Moore Capital Management, Lp0.21%211,705$5,680,045$6,139,445+$459,400+8.09%
Superstring Capital Management Lp3.77%196,709$5,277,702$5,704,561+$426,859+8.09%
Lpl Financial Llc0.00%188,637$5,061,118$5,470,473+$409,355+8.09%
Tidal Investments Llc0.02%184,124$4,940,047$5,339,596+$399,549+8.09%
Aimz Investment Advisors, Llc1.33%160,910$4,317,215$4,666,390+$349,175+8.09%
Folketrygdfondet0.08%160,773$4,313,540$4,662,417+$348,877+8.09%
Royal Bank Of Canada0.00%150,135$4,029,000$4,353,915+$324,915+8.06%
Charles Schwab Investment Management Inc0.00%127,571$3,422,730$3,699,559+$276,829+8.09%
Creative Planning0.00%118,596$3,181,928$3,439,284+$257,356+8.09%
Legacy Wealth Asset Management, Llc0.62%102,164$2,806,445$2,962,756+$156,311+5.57%
Jane Street Group, Llc0.00%98,432$2,640,931$2,854,528+$213,597+8.09%
Us Bancorp \De\0.00%95,548$2,563,553$2,770,892+$207,339+8.09%
Sei Investments Co0.00%93,012$2,495,624$2,697,348+$201,724+8.08%
Summittx Capital, L.P.0.07%84,354$2,263,218$2,446,266+$183,048+8.09%

Frequently asked questions about GMAB

  • Who owns the most GMAB stock?

    The largest holders of GMAB are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for GENMAB A/S -SP ADR (GMAB).

  • Is GMAB widely held by superinvestors?

    Many widely followed stocks like GMAB appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly GMAB is represented among the institutional managers we track.

  • What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?

    Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.